Literature DB >> 24577548

DNA Repair Gene Polymorphisms and Their Relation With DNA Damage, DNA Repair, and Total Antioxidant Capacity in Childhood Acute Lymphoblastic Leukemia Survivors.

Yildiz Dincer1, Selin Yüksel, Bahadir Batar, Mehmet Güven, Ilhan Onaran, Tiraje Celkan.   

Abstract

Oxidative stress and defective DNA repair are major contributory factors in the initiation and progression of carcinogenesis. Chemotherapy and radiotherapy cause oxidative DNA damage, consume antioxidant capacity, and impair DNA repair activity. These effects of chemotherapy and radiotherapy may be contributory factors in the development of secondary malignancy in cancer survivors. Basal, H2O2-induced, and postrepair DNA damage; urinary 8-hydroxydeoxyguanosine level as a marker of oxidatively damaged DNA; and serum total antioxidant capacity were measured; XPD Lys751Gln, XRCC1 Arg399Gln, and XRCC1 Arg194Trp polymorphisms were analyzed in childhood acute lymphoblastic leukemia (ALL) survivors. Basal and H2O2-induced DNA damage were found to be higher in the ALL survivor group versus the control group, however, there was no significant difference between the other parameters. No association was found between the examined parameters and polymorphisms of XPD 751 and XRCC1 399 and both the groups. XRCC1 194Trp allele was found to be associated with a low level of postrepair DNA damage in the ALL survivors. In conclusion, basal DNA damage and susceptibility to oxidation are high in childhood ALL survivors. This situation which may easily lead to occurrence of a secondary cancer does not seem to be a result of deficient DNA repair.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24577548     DOI: 10.1097/MPH.0000000000000133

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Associations Between XPD Lys751Gln Polymorphism and Leukemia: A Meta-Analysis.

Authors:  Min Wen; Bo Zhou; Xin Lin; Yunhua Chen; Jialei Song; Yanmei Li; Eldad Zacksenhaus; Yaacov Ben-David; Xiaojiang Hao
Journal:  Front Genet       Date:  2018-06-14       Impact factor: 4.599

2.  Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia.

Authors:  Ezeldine K Abdalhabib; Denise E Jackson; Badr Alzahrani; Elyasa M Elfaki; Alneil Hamza; Fehaid Alanazi; Elryah I Ali; Abdulrahman Algarni; Ibrahim Khider Ibrahim; Muhammad Saboor
Journal:  Pharmgenomics Pers Med       Date:  2021-12-22

Review 3.  Redox Control in Acute Lymphoblastic Leukemia: From Physiology to Pathology and Therapeutic Opportunities.

Authors:  Yongfeng Chen; Jing Li; Zhiqiang Zhao
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

4.  The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies.

Authors:  Fang Wang; Qian Zhao; Hai-Rong He; Ya-Jing Zhai; Jun Lu; Hai-Bo Hu; Jin-Song Zhou; Yong-Hua Yang; Yuan-Jie Li
Journal:  Onco Targets Ther       Date:  2015-11-06       Impact factor: 4.147

5.  Oxidative and Antioxidative Status Expressed as OSI Index and GSH/GSSG Ratio in Children with Bone Tumors after Anticancer Therapy Completion.

Authors:  Joanna Gajewska; Magdalena Chełchowska; Magdalena Rychłowska-Pruszyńska; Teresa Klepacka; Jadwiga Ambroszkiewicz
Journal:  J Clin Med       Date:  2022-03-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.